US Stock Market Move | The effectiveness of the COVID-19 vaccine is being questioned. Novavax, Inc. (NVAX.US) momentarily dropped over 25%.

10/04/2025

GMT Eight

On Thursday, Novavax, Inc. (NVAX.US) fell more than 25% to hit a new low for the year, now trading at $5.2. In terms of news, earlier the US Health Secretary, Robert Kennedy Jr., expressed doubts about the effectiveness of the company's COVID-19 vaccine as its approval in the US has been delayed.

H&H INTL HLDG (01112) achieved total revenue of approximately 3.17 billion yuan in the first quarter, a year-on-year increase of 10.4%.

The report stated that Trump privately admitted that tariffs would push the US economy to the brink of recession, but he does not want to experience a "Great Depression".

Contact: [email protected]

US Stock Market Move | The effectiveness of the COVID-19 vaccine is being questioned. Novavax, Inc. (NVAX.US) momentarily dropped over 25%.

RECOMMEND

China Automobile Dealers Association: The average daily trading volume of the used car market from April 7th to 13th reached 67,900 vehicles, a slight increase of 1.7% compared to the same period last year.

Tianfeng: Optimistic about technology domestic demand. Suggest focusing on military information technology + independent and controllable direction such as satellite.

Chen's C1 chip successfully lights up: targeting the billion-dollar automotive grade SoC track.